Soleno Therapeutics (SLNO)
Commercializes VYKAT XR for hyperphagia in Prader-Willi syndrome.
$53.01
0.00 (0.00%)
Delisted · May 15, 2026
Something off on this page? Send us feedback.
EPSReportedEstimate
Aug '24Nov '24Feb '25May '25Aug '25Nov '25Feb '26May '26
Reported−$0.57−$1.83−$1.27−$0.95−$0.09$0.47$0.80$0.59
Estimate−$0.63−$0.61−$0.63−$1.14−$0.53$0.06$0.64$0.73
Surprise+9.5%−200.0%−101.6%+16.7%+83.0%+717.4%+25.0%−19.2%
RevenueReportedEstimate
Aug '24Nov '24Feb '25May '25Aug '25Nov '25Feb '26May '26
Reported————$32.7M$66.0M$91.7M$94.6M
Estimate————$39.3M$88.5M$88.8M$93.8M
Surprise————−17.0%−25.4%+3.4%+0.9%
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Jun 2028 | $7.33 | — | — |
| Mar 2028 | $7.33 | — | — |
| Dec 2027 | $2.04 | — | — |
| Sep 2027 | $1.76 | — | — |
| Jun 2027 | $1.61 | — | — |
| Mar 2027 | $1.29 | — | — |
| Dec 2026 | $1.21 | — | — |
| Sep 2026 | $1.04 | — | — |
| Aug 2026 | $0.91 | — | — |
| May 2026 | $0.73 | $0.59 | −19.2% |
| Feb 2026 | $0.64 | $0.80 | +25.0% |
| Nov 2025 | $0.06 | $0.47 | +717.4% |
| Aug 2025 | −$0.53 | −$0.09 | +83.0% |
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| May 2015 | |||
| Mar 2015 | |||
| Dec 2014 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Jun 2028 | $7.33 | — | — | $94.6M | — | — | — |
| Mar 2028 | $7.33 | — | — | $820.4M | — | — | — |
| Dec 2027 | $2.04 | — | — | $208.4M | — | — | — |
| Sep 2027 | $1.76 | — | — | $187.8M | — | — | — |
| Jun 2027 | $1.61 | — | — | $175.0M | — | — | — |
| Mar 2027 | $1.29 | — | — | $154.4M | — | — | — |
| Dec 2026 | $1.21 | — | — | $136.3M | — | — | — |
| Sep 2026 | $1.04 | — | — | $122.1M | — | — | — |
| Aug 5, 2026 | $0.91 | — | — | $111.8M | — | — | — |
| May 7, 2026 | $0.73 | $0.59 | −19.2% | $93.8M | $94.6M | +0.9% | 0.0% |
| Feb 25, 2026 | $0.64 | $0.80 | +25.0% | $88.8M | $91.7M | +3.4% | −7.1% |
| Nov 4, 2025 | $0.06 | $0.47 | +717.4% | $88.5M | $66.0M | −25.4% | −26.6% |
| Aug 6, 2025 | −$0.53 | −$0.09 | +83.0% | $39.3M | $32.7M | −17.0% | −3.1% |
| May 7, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 6, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 21, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 10, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Jul 28, 2021 | |||||||
| May 5, 2021 | |||||||
| Mar 3, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 4, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 13, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 15, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 16, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 11, 2017 | |||||||
| May 11, 2017 | |||||||
| Mar 15, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Aug 12, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 24, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 7, 2015 | |||||||
| May 4, 2015 | |||||||
| Mar 10, 2015 | |||||||
| Dec 18, 2014 |